€37.1 B

Sanofi Revenue FY, 2015
Sanofi Revenue growth (FY, 2014 - FY, 2015), %10%
Sanofi Gross profit (FY, 2015)26.1 B
Sanofi Gross profit margin (FY, 2015), %70.5%
Sanofi Net income (FY, 2015)4.4 B

Sanofi Revenue

Sanofi revenue was €37.06 b in FY, 2015 which is a 9.7% year over year increase from the previous period.

Embed Graph

Sanofi Revenue Breakdown

Embed Graph

Sanofi revenue breakdown by business segment: 80.4% from Pharmaceuticals, 12.8% from Vaccines and 6.8% from Animal Health

Sanofi Income Statement

Annual

EURFY, 2013FY, 2014FY, 2015

Revenue

33 b33.8 b37.1 b

Revenue growth, %

2%10%

Cost of goods sold

10.3 b10.2 b10.9 b

Gross profit

22.6 b23.5 b26.1 b

Gross profit Margin, %

69%70%71%

R&D expense

4.6 b4.7 b5.1 b

General and administrative expense

8 b8.4 b9.4 b

Operating expense total

12.6 b13.1 b14.5 b

Depreciation and amortization

5.1 b3.3 b4.3 b

Interest expense

609 m598 m559 m

Interest income

111 m192 m178 m

Income tax expense

726 m(1.2 b)(709 m)

Net Income

3.9 b4.5 b4.4 b

Sanofi Cash Flow

Annual

EURFY, 2013FY, 2014FY, 2015

Cash From Operating Activities

6.4 b6.3 b7.2 b

Sanofi Ratios

EURY, 2015

Revenue/Employee

365.4 k
Report incorrect company information

Sanofi Operating Metrics

Y, 2013Y, 2014Y, 2015Y, 2016

Drugs Approved by FDA

1

Phase III Trials Products

11 9 8 7

Projects in R&D Pipeline

36 32 34 43
Report incorrect company information